| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 332 | 0 | 697 | 0 | 4.581 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 419 | 0 | 697 | 0 | 4.581 |
| Total Expenses - EUR | 32 | 59 | 36 | 17 | 124 | 362 | 107 | 175 | 144 | 423 |
| Gross Profit/Loss - EUR | -32 | -59 | -36 | -17 | -124 | 57 | -107 | 523 | -144 | 4.158 |
| Net Profit/Loss - EUR | -32 | -59 | -36 | -17 | -124 | 47 | -107 | 441 | -144 | 3.525 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bio Alice S.r.l.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 80 | 47 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 36 | 8 | 2 | 0 | 0 | 81 | 14 | 413 | 206 | 4.024 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19 | 19 | 0 |
| Cash | 36 | 8 | 2 | 0 | 0 | 81 | 14 | 394 | 188 | 4.024 |
| Shareholders Funds | 13 | -46 | -82 | -97 | -220 | -168 | -276 | 166 | 21 | 3.546 |
| Social Capital | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 | 40 |
| Debts | 103 | 7 | 6 | 6 | 130 | 249 | 290 | 247 | 185 | 478 |
| Income in Advance | 96 | 95 | 93 | 91 | 89 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 5.0415 | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Bio Alice S.r.l.